CGON

NASDAQStock

CG Oncology, Inc. Common stock

$62.03-2.63 (-4.07%)

52-Week Range

$15.59

$64.66

Key Stats

Market Cap

5.2B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.19

Volume

1.5M

Avg Volume

1.2M

Performance

+21.79%

+57.94%

+86.88%

YTD

+54.73%

+142.90%

+73.96%

Price Chart

ETF Exposure

CGON is held by 83 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
HDG	ProShares - Hedge Replication ETF	0.02%	62	$4K	$23.2M	0.95%
ONEQ	FIDELITY NASDAQ COMPOSITE INDEX ETF	0.02%	24,251	$1.5M	$9.01B	0.21%
DCOR	Dimensional - US Core Equity 1 ETF	0.01%	4,611	$290K	$2.68B	0.14%
DFAC	Dimensional - US Core Equity 2 ETF	0.01%	58,595	$3.7M	$41.36B	0.17%
DFAU	Dimensional - US Core Equity Market ETF	0.01%	13,756	$864K	$10.55B	0.12%
TILT	FlexShares Morningstar U.S. Market Factor Tilt Index Fund	0.01%	2,576	$162K	$1.90B	0.26%
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.01%	85,376	$5.4M	$81.53B	0.03%
IWV	iShares Russell 3000 ETF	0.01%	16,126	$1.0M	$17.58B	0.20%
SCHB	Schwab U.S. Broad Market ETF	0.01%	38,947	$2.4M	$38.14B	0.03%
VTI	Vanguard Total Stock Market ETF	0.01%	2,177,838	$113.4M	$2.10T	0.03%
VTHR	Vanguard Russell 3000 ETF	0.00%	4,695	$244K	$5.50B	0.06%
AVUS	Avantis U.S. Equity ETF	0.00%	4,840	$304K	$11.08B	0.15%
DXUV	Dimensional - US Vector Equity ETF	0.00%	163	$10K	$358.0M	0.28%
GTPE	Goldman Sachs MSCI World Private Equity Return Tracker ETF	0.00%	26	$2K	$26.4M	0.50%
DFUS	Dimensional - US Equity Market ETF	0.00%	7,388	$464K	$18.80B	0.09%
EAOA	iShares ESG Aware 80/20 Aggressive Allocation ETF	0.00%	16	$1K	$33.4M	0.34%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	36	$2K	$59.0M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	30	$2K	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	20	$1K	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	15	$941	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	7	$418	$9.5M	0.12%
EAOK	iShares ESG Aware 30/70 Conservative Allocation ETF	0.00%	2	$104	$9.0M	0.30%
EAOM	iShares ESG Aware 40/60 Moderate Allocation ETF	0.00%	2	$129	$8.3M	0.31%
EAOR	iShares ESG Aware 60/40 Balanced Allocation ETF	0.00%	11	$701	$30.3M	0.32%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	16	$977	$81.5M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	26	$2K	$81.7M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	30	$2K	$64.1M	0.11%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	5	$295	$61.4M	0.09%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	1,411	$77K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	1,411	$77K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	1,411	$77K	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.00%	1,411	$77K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	1,411	$77K	$3.7M	0.70%

PreviousPage 2 of 2

About CGON ETF Exposure

CG Oncology, Inc. Common stock (CGON) is held by 83 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 5.2B, CGON is a widely held institutional stock. The stock currently trades at $62.03. Investors can gain exposure to CGON through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CGON, sorted by portfolio weight.